Nucleophosmin in Acute Myelogenous Leukemia
- 28 April 2005
- journal article
- letter
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 352 (17), 1819-1820
- https://doi.org/10.1056/nejm200504283521719
Abstract
Falini et al. (Jan. 20 issue)1 report an abnormal cytoplasmic localization of nucleophosmin (NPM) in 35 percent of specimens from patients with acute myelogenous leukemia. In these patients the NPM gene was mutated, which resulted in a frame shift. The authors state that tryptophan residues at positions 288 and 290 of NPM played a role in the cytoplasmic translocation of NPM. However, these residues are responsible only for nucleolar localization of NPM, not for cytoplasmic localization.2 We found a motif containing leucine-valine residues, known as the nuclear-export-signal (NES) motif, in the C-terminal of mutated NPMs A to F in Figure 4B of the article ( Figure 1 ). The typical nuclear-export signal consists of a short stretch of hydrophobic amino acids (predominantly leucines) and fits the consensus sequence Lx(1-3)Lx(2-3)LxL (with x indicating any residues).3 NES-containing molecules are recognized by nuclear export receptor CRM1 and are then exported to cytoplasm.4 We believe that the NES generated by the mutation of the NPM gene is important for cytoplasmic localization of NPM and tumorigenesis in acute myelogenous leukemia.Keywords
This publication has 3 references indexed in Scilit:
- Cytoplasmic Nucleophosmin in Acute Myelogenous Leukemia with a Normal KaryotypeThe New England Journal of Medicine, 2005
- Tryptophans 286 and 288 in the C-terminal Region of Protein B23.1 are Important for Its Nucleolar LocalizationBioscience, Biotechnology, and Biochemistry, 2002
- A Comparison of the Activity, Sequence Specificity, and CRM1-Dependence of Different Nuclear Export SignalsExperimental Cell Research, 2000